In-depth analysis: Will pemetinib/pemetinib be free for life after paying RMB 100,000 out of pocket?
The statement that pemigatinib will be free for life after spending RMB 100,000 on your own is inaccurate and somewhat misleading. The price and cost of drugs are determined by a variety of complex factors, including but not limited to drug research and development costs, production costs, market demand, and medical insurance policies. Therefore, there is no so-called universal policy of "free for life after spending 100,000 on your own". This statement may stem from a misunderstanding or misinformation about how drug payments are made in certain circumstances.

Pemetinib is a cancer drug used to treat cholangiocarcinoma (biliary tract or bile duct cancer) in adults when the cancer cells have an abnormal form of a receptor (target) on their surface called FGFR2. Pemetinib is used when the cancer has spread to other parts of the body or cannot be removed with surgery and has worsened after previous treatment with at least one cancer drug. Pemigatinib contains the active ingredient pemigatinib.
Pemetinib/ As a targeted drug targeting specific gene mutations, Pemetinib is indeed relatively expensive, which undoubtedly puts great financial pressure on many patients. In order to alleviate this pressure, some hospitals, charities or pharmaceutical companies may launch various forms of preferential policies or assistance programs, such as drug discounts, fee exemptions or charitable drug donations. However, these discounts and assistance usually have certain conditions and restrictions, and not all patients can enjoy them.
For pemetinib/ Regarding the cost of targeted drugs such as pemetinib, patients should actively communicate with doctors, hospitals or relevant institutions to understand the true drug prices and costs, as well as possible preferential policies and assistance projects. At the same time, patients should also rationally choose drugs and treatment plans based on their own economic status and disease needs to ensure the effectiveness and safety of treatment.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)